Event Brief
Nov 25, 2025 at 11:04 PM ET
FDA Approves New Zantac Formula After 5-Year Ban
By The BriefBrief
FDA greenlights reformulated Zantac, addressing cancer concerns from 2020 withdrawal.
WHO: FDA, local pharmacies, healthcare providers
WHAT: Approval of reformulated Zantac antacid
WHEN: Nov 25, 2025 at 7:00 PM ET
WHERE: Washington, DC
WHY: To provide a safer option for heartburn relief after safety concerns
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21417 of 21417
Same format. Every time.
Continue reading — sign in or create a free account with
